Skip to main content
Top

International Journal of Hematology

Issue 5/2008

Content (18 Articles)

Original Article

Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype

Kyoko Sugimoto, Makoto Murata, Makoto Onizuka, Yoshihiro Inamoto, Seitaro Terakura, Yachiyo Kuwatsuka, Taku Oba, Koichi Miyamura, Yoshihisa Kodera, Tomoki Naoe

Original Article

Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells: application for allogeneic transplantation

Hiroki Torikai, Yoshiki Akatsuka, Yasushi Yatabe, Yasuo Morishima, Yoshihisa Kodera, Kiyotaka Kuzushima, Toshitada Takahashi

Original Article

Risk of malignant lymphoma following viral hepatitis infection

Pierluigi Cocco, Giovanna Piras, Maria Monne, Antonella Uras, Attilio Gabbas, Maria G. Ennas, Angelo Palmas, Marco Murineddu, Stefania Collu, Massimo Melis, Marco Rais, Pierfelice Todde, Maria G. Cabras, Emanuele Angelucci, Giovannino Massarelli, Alexandra Nieters

Original Article

Current status of development of anticancer agents in Japan

Tomohiro Morita, Akiko Hori, Hiroto Narimatatsu, Tetsuya Tanimoto, Masahiro Kami

Erratum

Erratum to: Current status of development of anticancer agents in Japan

Tomohiro Morita, Akiko Hori, Hiroto Narimatsu, Tetsuya Tanimoto, Masahiro Kami

Original Article

Primary non-Hodgkin’s lymphoma of the breast: eight-year follow-up experience

Hai-Yi Guo, Xin-Min Zhao, Jin Li, Xi-Chun Hu

Original Article

The transcriptional activity of WT1 gene promoter and enhancer in cell lines with diverse tissue origin

Shaoyan Hu, Zixing Chen, Weiying Gu, Ruihua Chen, Ye Zhao, Jiannong Cen

Original Article

Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin

Junya Kuroda, Yuri Kamitsuji, Shinya Kimura, Eishi Ashihara, Eri Kawata, Yoko Nakagawa, Miki Takeuichi, Yoshihide Murotani, Asumi Yokota, Ruriko Tanaka, Michael Andreeff, Masafumi Taniwaki, Taira Maekawa

Case Report

Severe degenerative change of multiple organs mediated by chronic active Epstein–Barr virus infection with infected T-cell expansion

Michihide Tokuhira, Atsushi Iizuka, Reiko Watanabe, Naoya Sekiguchi, Norihide Sato, Chen-Kang Chien, Yasunobu Sekiguchi, Tomoe Nemoto, Kyoko Hanzawa, Jun-ichi Tamaru, Shinji Itoyama, Hiroshi Suzuki, Tsutomu Takeuchi, Shigehisa Mori, Masahiro Kizaki

Case Report

Leukemic transformation of Langerhans cell sarcoma

Kousuke Sumida, Yuya Yoshidomi, Hiroko Koga, Nobuo Kuwahara, Eijo Matsuishi, Kennosuke Karube, Koichi Oshima, Hisashi Gondo

Case Report

ESHAP therapy effective in a patient with Langerhans cell sarcoma

Akihide Yoshimi, Keiki Kumano, Toru Motokura, Yutaka Takazawa, Satoshi Oota, Shigeru Chiba, Tsuyoshi Takahashi, Masashi Fukayama, Mineo Kurokawa

Case Report

Herpes simplex encephalitis and subsequent cytomegalovirus encephalitis after chemoradiotherapy for central nervous system lymphoma: a case report and literature review

Hiroshi I. Suzuki, Akira Hangaishi, Noriko Hosoya, Takuro Watanabe, Yoshinobu Kanda, Toru Motokura, Shigeru Chiba, Mineo Kurokawa

Case Report

Pulmonary embolism in a patient with multiple myeloma receiving thalidomide–dexamethasone therapy

Wen-Juei Jeng, Ming-Chung Kuo, Lee-Yung Shih, Pao-Hsien Chu

Case Report

Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy

P. Machado, J. M. Raya, T. Martín, L. Morabito, M. L. Brito, J. M. Rodríguez-Martín

Case Report

Optic disc hemorrhages in a patient with hemophilia A

Teng-Yi Wang, Chi-Ting Horng, Shin-Nan Cheng, Chia-Hung Li, Jiann-Torng Chen, Ming-Ling Tsai

Letter to the Editor

A rare case of co-existent aggressive natural killer cell and acute monocytic leukemia with cytomegalovirus infection

Jian Huang, Wanmao Ni, Lei Wang, Wenjing Zhou, Jie Jin

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine